Meeting of the National Advisory Council on Nurse Education and Practice, 86907-86908 [2023-27618]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 240 / Friday, December 15, 2023 / Notices
offenses he pled guilty to, including the
offenses of: (1) importation into the
United States a quantity of ethylone, a
Schedule I Controlled Substance in
violation of 21 U.S.C. 952(a) and
960(a)(1); (2) importation into the
United States quantities of TURINABOL
and DIANABOL, anabolic steroids, and
Schedule III Controlled Substances in
violation of 21 U.S.C. 952(b) and
960(a)(1); and (3) smuggling goods into
the United States, that is, alpha-PVP
ethylone, Schedule I Controlled
Substances, and TURINBOL and
DIANABOL, Schedule III Controlled
Substances, in violation of 18 U.S.C.
545. FDA’s finding that debarment is
appropriate is based on the felony
conviction referenced herein. The
factual basis for this conviction is as
follows:
As contained in the superseding
indictment, filed on March 22, 2018, the
Defendant’s motion for downward
variance, filed on April 24, 2023, and
the Government’s sentencing
memorandum, filed April 24, 2023,
from Mr. Nagy’s case, Mr. Nagy was the
owner and operator of Prescription
Nutrition, Prescription Protein, and
N.O.B. Industries located in
Pennsylvania. From on or about June
2014 to on or about September 2014,
Mr. Nagy imported various types of
controlled substances which he then
capsuled and distributed to clients.
Specifically, from on or about June 2014
to on or about July 2014, Mr. Nagy
illegally imported ethylone. In July
2014, he also illegally imported
TURINABOL and DIANABOL. In
addition, from June 2014 until on or
about September 2014, Mr. Nagy
illegally imported alpha-PVP, ethylone,
TURINABOL, and DIANABOL. All the
controlled substances Mr. Nagy
imported and smuggled into the country
came from China.
As a result of this conviction, FDA
sent Mr. Nagy, by certified mail, on
September 20, 2023, a notice proposing
to debar him for a 15-year period from
importing or offering for import any
drug into the United States. The
proposal was based on a finding under
section 306(b)(3)(C) of the FD&C Act
that Mr. Nagy’s three felony convictions
that included: (1) importation into the
United States a quantity of ethylone, a
Schedule I Controlled Substance in
violation of 21 U.S.C. 952(a) and
960(a)(1); (2) importation into the
United States quantities of TURINABOL
and DIANABOL, anabolic steroids and
Schedule III Controlled Substances in
violation of 21 U.S.C. 952(b) and
960(a)(1); and (3) smuggling goods into
the United States, that is, alpha-PVP
ethylone, Schedule I Controlled
VerDate Sep<11>2014
17:57 Dec 14, 2023
Jkt 262001
Substances, and TURINBOL,
DIANABOL, Schedule III Controlled
Substances in violation of 18 U.S.C. 545,
were for conduct relating to the
importation into the United States of
any drug or controlled substance
because he imported controlled
substances into the United States in
order to capsule portions of the drugs to
sell to clients. In proposing a debarment
period, FDA weighed the considerations
set forth in section 306(c)(3) of the
FD&C Act that it considered applicable
to Mr. Nagy’s offenses and concluded
that each offense warranted the
imposition of a 5-year period of
debarment, to run consecutively, for a
total of a 15-year period of debarment.
The proposal informed Mr. Nagy of
the proposed debarment and offered
him an opportunity to request a hearing,
providing him 30 days from the date of
receipt of the letter in which to file the
request, and advised him that failure to
request a hearing constituted a waiver of
the opportunity for a hearing and of any
contentions concerning this action. Mr.
Nagy received the proposal and notice
of opportunity for a hearing on
September 22, 2023. Mr. Nagy failed to
request a hearing within the timeframe
prescribed by regulation and has,
therefore, waived his opportunity for a
hearing and waived any contentions
concerning his debarment (21 CFR part
12).
II. Findings and Order
Therefore, the Assistant
Commissioner, Office of Human and
Animal Food Operations, under section
306(b)(3)(C) of the FD&C Act, under
authority delegated to the Assistant
Commissioner, finds that Adam Michael
Nagy been convicted of three felonies
under federal law for conduct relating to
the importation into the United States of
any drug or controlled substance. FDA
finds that the offense should be
accorded a debarment period of 15 years
as provided by section 306(c)(2)(A)(iii)
of the FD&C Act.
As a result of the foregoing finding,
Mr. Nagy is debarred for a period of 15
years from importing or offering for
import any drug into the United States,
effective (see DATES). Pursuant to
section 301(cc) of the FD&C Act (21
U.S.C. 331(cc)), the importing or
offering for import into the United
States of any drug by, with the
assistance of, or at the direction of Mr.
Nagy is a prohibited act.
Dated: December 11, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–27557 Filed 12–14–23; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
86907
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the National Advisory
Council on Nurse Education and
Practice
Health Resources and Services
Administration, Department of Health
and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the National
Advisory Council on Nurse Education
and Practice (NACNEP) will hold public
meetings for the 2024 calendar year
(CY). Information about NACNEP,
agendas, and materials for these
meetings can be found on the NACNEP
website at https://www.hrsa.gov/
advisory-committees/nursing.
DATES: NACNEP meetings will be on (all
in Eastern Time):
• March 14, 2024, 10 a.m.–4 p.m. and
March 15, 2024, 10 a.m.–4 p.m.;
• May 9, 2024, 10 a.m.–4 p.m.;
• August 7, 2024, 10 a.m.–4 p.m. and
August 8, 2024, 10 a.m.–4 p.m.; and
• December 5, 2024, 8 a.m.–5 p.m.
and December 6, 2024, 8 a.m.–2 p.m.
ADDRESSES: Meetings may be held in
person, via teleconference, and/or video
conference. In-person meetings will be
held at 5600 Fishers Lane, Rockville,
Maryland 20857. For updates on how
the meeting will be held and
instructions for joining meetings, visit
the NACNEP website at https://
www.hrsa.gov/advisory-committees/
nursing/meetings 14 business days
before the date of the meeting.
FOR FURTHER INFORMATION CONTACT:
Justin Bala-Hampton, Designated
Federal Official, NACNEP, Bureau of
Health Workforce, Division of Nursing
and Public Health, Health Resources
and Services Administration, 5600
Fishers Lane, 11N100D, Rockville,
Maryland 20857; 301–443–5260; or
Jbala-hampton@hrsa.gov.
SUPPLEMENTARY INFORMATION: NACNEP
provides advice and recommendations
to the Secretary of Health and Human
Services on policy, program
development, and other matters of
significance concerning the activities
under title VIII of the Public Health
Service Act, including the range of
issues relating to the nurse workforce,
education, and practice improvement.
NACNEP also prepares and submits an
annual report to the Secretary of Health
and Human Services and Congress
describing its activities, including
SUMMARY:
E:\FR\FM\15DEN1.SGM
15DEN1
86908
Federal Register / Vol. 88, No. 240 / Friday, December 15, 2023 / Notices
NACNEP’s findings and
recommendations concerning activities
under Title VIII, as required by the
Public Health Service Act.
Since priorities dictate meeting times,
be advised that times and agenda items
are subject to change. For CY 2024
meetings, agenda items may include,
but are not limited to, the nursing
workforce (e.g., nursing shortage,
distribution, supply, and access)
nursing practice improvement, nursing
education, nursing work environment
and support, and other Title VIII
program activities. Refer to the NACNEP
website listed above for all current and
updated information concerning the CY
2024 NACNEP meetings. Agendas and
meeting materials that will be posted up
to 30 calendar days but no later 14
calendar days before the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACNEP
should be sent to Justin Bala-Hampton
using the contact information above at
least 5 business days before the meeting.
Individuals who need special
assistance or another reasonable
accommodation should notify Justin
Bala-Hampton at the email address and
phone number listed above at least 10
business days before the meeting(s) they
wish to attend. In-person meetings
occur in a federal government building,
and attendees must pass a security
check to enter the building. Non-U.S.
citizen attendees must notify Justin
Bala-Hampton of their planned
attendance at least 20 business days
prior to the meeting to facilitate their
entry into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–27618 Filed 12–14–23; 8:45 am]
BILLING CODE 4165–15–P
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Council on Graduate
Medical Education
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
17:57 Dec 14, 2023
Jkt 262001
ACTION:
Notice.
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Council on
Graduate Medical Education (COGME or
Council) will hold public meetings for
the 2024 calendar year (CY).
Information about COGME, agendas,
and materials for these meetings can be
found on the COGME website at https://
www.hrsa.gov/advisory-committees/
graduate-medical-edu/meetings.
DATES: COGME meetings will be held
on:
• March 4, 2024, 9:00 a.m.–5:00 p.m.
Eastern Time (ET) and March 5, 2024,
9:00 a.m.–2:00 p.m. ET; and
• September 12, 2024, 10:00 a.m.–
5:00 p.m. ET and September 13, 2024,
10:00 a.m.–3:00 p.m. ET.
ADDRESSES: The meeting scheduled for
March 2024 will be held in-person at
5600 Fishers Lane, Rockville, Maryland
20857. The meeting scheduled for
September 2024 will be held remotely
by teleconference/webinar. The meeting
format is subject to change as needed.
For any updates on how the meetings
will be held, visit the COGME website
30 business days before the date of the
meeting, where instructions for joining
meetings will be posted. For meeting
information updates, go to the COGME
website meeting page at https://
www.hrsa.gov/advisory-committees/
graduate-medical-edu/meetings.
FOR FURTHER INFORMATION CONTACT: Dr.
Curi Kim, Designated Federal Official,
Division of Medicine and Dentistry,
Bureau of Health Workforce, HRSA,
5600 Fishers Lane, Room 15N35,
Rockville, Maryland 20857; 301–945–
5827; or CKim@hrsa.gov.
SUPPLEMENTARY INFORMATION: COGME
provides advice and recommendations
to the Secretary of HHS and Congress on
policy, program development, and other
matters of significance regarding the
issues listed in section 762(a)(1) of the
Public Health Service Act. Issues
addressed by the COGME include the
supply and distribution of the physician
workforce in the United States,
including any projected shortages or
excesses; international medical
graduates; the nature and financing of
undergraduate and graduate medical
education; appropriation levels for
certain programs under Title VII of the
Public Health Service Act; and
deficiencies in databases concerning the
supply and distribution of the physician
workforce and postgraduate programs
for training physicians. COGME submits
reports to the Secretary of HHS; the
Senate Committee on Health, Education,
Labor and Pensions; and the House of
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 9990
Representatives Committee on Energy
and Commerce. Additionally, COGME
encourages entities providing graduate
medical education to conduct activities
to voluntarily achieve the
recommendations of the Council related
to appropriate efforts to be carried out
by hospitals, schools of medicine,
schools of osteopathic medicine, and
accrediting bodies with respect to the
supply and distribution of physicians in
the United States; current and future
shortages or excesses of physicians in
medical and surgical specialties and
subspecialties; and issues relating to
international medical graduates,
including efforts for changes in
undergraduate and graduate medical
education programs.
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
For CY 2024 meetings, agenda items
may include, but are not limited to,
discussions on team-based care,
graduate medical education data, and
the topic areas listed above. Refer to the
COGME website listed above for all
current and updated information
concerning the CY 2024 COGME
meetings, including draft agendas and
meeting materials that will be posted 30
calendar days before the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to COGME
should be sent to Dr. Kim using the
contact information above at least 5
business days before the meeting
date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Dr. Kim
using the contact information listed
above at least 10 business days before
the meeting(s) they wish to attend.
Since all in-person meetings occur in a
federal government building, attendees
must go through a security check to
enter the building. Non-U.S. Citizen
attendees must notify HRSA of their
planned attendance at least 20 business
days prior to the meeting in order to
facilitate their entry into the building.
All attendees are required to present
government-issued identification prior
to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–27500 Filed 12–14–23; 8:45 am]
BILLING CODE 4165–15–P
E:\FR\FM\15DEN1.SGM
15DEN1
]]>Agencies
[Federal Register Volume 88, Number 240 (Friday, December 15, 2023)]
[Notices]
[Pages 86907-86908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27618]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the National Advisory Council on Nurse Education and
Practice
AGENCY: Health Resources and Services Administration, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the National Advisory Council on Nurse Education
and Practice (NACNEP) will hold public meetings for the 2024 calendar
year (CY). Information about NACNEP, agendas, and materials for these
meetings can be found on the NACNEP website at https://www.hrsa.gov/advisory-committees/nursing.
DATES: NACNEP meetings will be on (all in Eastern Time):
March 14, 2024, 10 a.m.-4 p.m. and March 15, 2024, 10
a.m.-4 p.m.;
May 9, 2024, 10 a.m.-4 p.m.;
August 7, 2024, 10 a.m.-4 p.m. and August 8, 2024, 10
a.m.-4 p.m.; and
December 5, 2024, 8 a.m.-5 p.m. and December 6, 2024, 8
a.m.-2 p.m.
ADDRESSES: Meetings may be held in person, via teleconference, and/or
video conference. In-person meetings will be held at 5600 Fishers Lane,
Rockville, Maryland 20857. For updates on how the meeting will be held
and instructions for joining meetings, visit the NACNEP website at
https://www.hrsa.gov/advisory-committees/nursing/meetings 14 business
days before the date of the meeting.
FOR FURTHER INFORMATION CONTACT: Justin Bala-Hampton, Designated
Federal Official, NACNEP, Bureau of Health Workforce, Division of
Nursing and Public Health, Health Resources and Services
Administration, 5600 Fishers Lane, 11N100D, Rockville, Maryland 20857;
301-443-5260; or [email protected].
SUPPLEMENTARY INFORMATION: NACNEP provides advice and recommendations
to the Secretary of Health and Human Services on policy, program
development, and other matters of significance concerning the
activities under title VIII of the Public Health Service Act, including
the range of issues relating to the nurse workforce, education, and
practice improvement. NACNEP also prepares and submits an annual report
to the Secretary of Health and Human Services and Congress describing
its activities, including
[[Page 86908]]
NACNEP's findings and recommendations concerning activities under Title
VIII, as required by the Public Health Service Act.
Since priorities dictate meeting times, be advised that times and
agenda items are subject to change. For CY 2024 meetings, agenda items
may include, but are not limited to, the nursing workforce (e.g.,
nursing shortage, distribution, supply, and access) nursing practice
improvement, nursing education, nursing work environment and support,
and other Title VIII program activities. Refer to the NACNEP website
listed above for all current and updated information concerning the CY
2024 NACNEP meetings. Agendas and meeting materials that will be posted
up to 30 calendar days but no later 14 calendar days before the
meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to NACNEP should be
sent to Justin Bala-Hampton using the contact information above at
least 5 business days before the meeting.
Individuals who need special assistance or another reasonable
accommodation should notify Justin Bala-Hampton at the email address
and phone number listed above at least 10 business days before the
meeting(s) they wish to attend. In-person meetings occur in a federal
government building, and attendees must pass a security check to enter
the building. Non-U.S. citizen attendees must notify Justin Bala-
Hampton of their planned attendance at least 20 business days prior to
the meeting to facilitate their entry into the building. All attendees
are required to present government-issued identification prior to
entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-27618 Filed 12-14-23; 8:45 am]
BILLING CODE 4165-15-P
